Acellular pertussis vaccine: Recommendations for use as the initial series in infants and children

Pediatrics

Volumn 99, Issue 2, 1997, Pages 282-288

  Halsey, N A ^a   Chesney, P J ^a   Gerber, M A ^a   Gromisch, D S ^a   Kohl, S ^a   Marcy, S M ^a   Marks, M I ^a   Murray, D L ^a   Overall J C , Jr ^a   Pickering, L K ^a   Whitley, R J ^a   Yogev, R ^a   Peter, G ^a   Hall, C B ^a   Hadler, S ^a   Breiman, R ^a   Hardegree, M C ^a   Jacobs, R F ^a   MacDonald, N E ^a   Orenstein, W A ^a   Rabinovich, N R ^a   Schwartz, B ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEMAGGLUTININ; PERTUSSIS VACCINE; PLACEBO;

ANOREXIA; CHILD; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; FEVER; HUMAN; IMMUNOGENICITY; INFANT; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; SOMNOLENCE; VACCINATION;

CHILD, PRESCHOOL; HUMANS; IMMUNIZATION SCHEDULE; INFANT; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 0030994693     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.99.2.282     Document Type: Review

References (21)

1. Decker MD, Edwards KM, Steinhoff MC, et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics. 1995; 96(suppl):557-566
2. Edwards DM, Meade BD, Decker MD, et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics. 1995; 96(suppl):548-557
3. Trollfors B, Taranger J, Lagergard T, et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med. 1995;333:1045-1050
4. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med. 1996;334:341-348
5. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996;334:349-355
6. Schmitt HJ, Wirsing von König CH, Neiss A, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA. 1996;275:37-41
7. International Symposium on Pertussis Vaccine Trials, Rome; October 30-November 1, 1995. In: Trial Synopses. Rome: Institute Superiore di Sanità; 1995
8. Ad Hoc Group for the Study of Pertussis Vaccines. Placebo-controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events. Lancet. 1988;1:955-960. Published erratum appears in Lancet. 1988;1:1238
9. Storsaeter J, Blackwelder WC, Hollander HO. Pertussis antibodies, protection, and vaccine efficacy after household exposure. Am J Dis Child. 1992;146:167-172
10. Blumberg DA, Mink CM, Cherry JD, et al. Comparison of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants. J Pediatr. 1991;119:194-204
11. Kimura M, Kuno-Sakai H, Sato Y, et al. A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids: outcomes in 3-to 8-month old infants, 9-to 23-month old infants and children, and 24-to 30-month old children. Am J Dis Child. 1991;145:734-741
12. American Academy of Pediatrics, Committee on Infectious Diseases. Acellular pertussis vaccines: recommendations for use as the fourth and fifth doses. Pediatrics. 1992;90:121-123
13. American Academy of Pediatrics. Pertussis. In: Peter G, ed. 1994 Red Book. Report of the Committee on Infectious Diseases. 23rd ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1994:355-367
14. Centers for Disease Control and Prevention. Update: childhood vaccine preventable diseases - United States, 1994. MMWR. 1995;43:718-719
15. Onorato IM, Wassilak SG, Meade B. Efficacy of whole-cell pertussis vaccine in pre-school children in the United States. JAMA. 1992;267: 2745-2749
16. Rosenthal S, Chen R, Hadler SC. The safety of acellular pertussis vs. whole-cell pertussis vaccine: a post marketing assessment. Arch Pediatr Adolesc Med. 1996;150:457-460
17. Committee on Infectious Diseases, American Academy of Pediatrics. The relationship between pertussis vaccine and brain damage: reassessment. Pediatrics. 1991;88:397-400
18. American Academy of Pediatrics, Committee on Infectious Diseases. The status of acellular pertussis vaccine: current perspectives. Pediatrics. 1991;88:401-405
19. Halsey NA, Peter G. New developments with pertussis vaccines. Pediatrics. 1995;96:970-971
20. Edwards KM, Decker MD, Graham BS, et al. Adult immunization with acellular pertussis vaccine. JAMA. 1993;269:53-56
21. Nennig ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA. 1996;275: 1672-1674